SUBSCRIBE

Breaking News on Supplements & Nutrition - North AmericaEU edition

GNC, Cellucor and Woodbolt targeted in new DMAA lawsuit

GNC, Cellucor Sports Nutrition and others have been accused of misleading consumers over the source, regulatory status and safety of the controversial stimulant DMAA (1,3 Dimethylamylamine) in a new class...

AHA GRAS attack reaction: Why self-affirmed GRAS is not ‘GRAS lite’

Experts in helping firms navigate the GRAS (generally recognized as safe) process say the American Heart Association (AHA) made some valid points in its recent attack on GRAS, but argue...

Self-affirmed GRAS under fire as AHA steps up sodium reduction campaign

There are serious weaknesses in the system that allows firms to self-affirm the safety of foods without the approval or knowledge of the Food and Drug Administration (FDA), according to...

Martek/DSM ‘fishless fish oil’ gains momentum as firms seek EPA and DHA … minus the fish

Martek’s new algal EPA/DHA blend - the ‘fishless fish oil’ - is gaining momentum in the market with recent launches including Schiff’s MegaRed Plant-Omega supplements and Darigold Omega-3 2% milk....

UNPA: We agree with AHPA on DMAA labeling

The United Natural Products Alliance (UNPA) says it agrees with the AHPA that supplement makers should not label the stimulant DMAA (1,3-Dimethylamylamine) as geranium oil or as any part of...

CRN UK on DMAA: “The law is clear. DMAA is illegal in the EU and should be stripped from shelves”

Trade in sports products containing the controversial stimulant DMAA (methylhexaneamine/1,3-dimethylamylamine) is illegal in the European Union, and should be brought to an immediate halt by EU and member state authorities,...

GNC: There is no scientific evidence to prove causal link between DMAA and AERs

GNC has weighed into the debate over the stimulant DMAA (1,3-Dimethylamylamine) following the recall of DMAA-containing products from stores on military bases while the Department of Defense conducts a probe...

FDA will 'consider whether regulatory action is warranted on DMAA'

The Food and Drug Administration (FDA) has weighed into the debate over the stimulant DMAA (1,3-Dimethylamylamine, also known as methylhexaneamine or MHA), which has garnered more bad press in recent...

Fabricant on NDI draft guidance: Thanks for your 146,000 pages of comments. We’ll get back to you…

Those hoping the Food and Drug Administration (FDA) is preparing for a major climb down on its draft guidance on new dietary ingredients (NDIs) will draw little comfort from comments...

ABC: Solvents white paper could help inform NDI debate

An authoritative new guide to 23+solvents used in the production of botanical extracts for dietary ingredients could help inform the debate on ‘chemical alteration’ at the heart of the FDA’s...

Jarrow Formulas FOIA request on NDIs: ‘In sum, FDA has told us to drop dead’

Jarrow Formulas is still waiting for a “substantive response” from the Food and Drug Administration (FDA) to a Freedom of Information Act (FOIA) request submitted more than two months ago...

DSHEA co-author is ‘alarmed’ by NDI guidance

The chief architect of the 1994 Dietary Supplement Health and Education Act (DSHEA) does not believe the Food and Drug Administration’s (FDA’s) draft guidance on new dietary ingredients (NDIs) is...

AHPA: FDA will be 'laughed out of court' if it sticks to its guns on supplement-specific NDI notifications

The FDA will be “laughed out of court” if it tries to defend enforcement action against supplement manufacturers based on the argument that new dietary ingredient (NDI) notifications should apply...

Hatch NDI guidance meeting: File comments for now, then explore legal avenues …

A range of options – “judicial, administrative and Congressional” – is being explored by the dietary supplements industry should the FDA prove unwilling to make substantial changes to its controversial...

Emord on NDI guidance: Politics has prevailed over science and common sense

If sufficient pressure is exerted on key members of Congress, it is not beyond the realms of possibility that the FDA might suspend its draft guidance on NDIs (new dietary...

Supplements trade: NDI guidance can be salvaged, but give us more time

If stakeholders are granted more time to respond to the FDA’s draft guidance on new dietary ingredients (NDIs), it should be possible to reach a compromise that will satisfy regulators...

NDI guidance public comments: Don't revise it, ditch it

The FDA should calculate how much complying with its guidance on new dietary ingredients (NDIs) will cost before forcing the supplements industry to embark on a “giant paperwork exercise” that...

Biotech firm launches mission to commercialize novel prebiotics

A New Orleans-based biotech firm on a mission to commercialize “novel evidence-based prebiotic products” is aiming to bring its first products to market next year.

Dormant antioxidant has ‘unparalleled’ benefits

A Beverly Hills-based biotech firm is planning to launch a series of supplements and functional foods containing ergothioneine, an antioxidant it claims has “unparalleled” benefits that has hidden its light...

New entrant set to shake up algal omega-3 market

A new player is poised to enter the vegetarian omega-3 market with a production process it claims will enable it to make the long chain fatty acids EPA (eicosapentaenoic acid)...

ChromaDex: We’ll do for nicotinamide riboside what we did for pterostilbene

Nicotinamide riboside (NR) - the latest addition to ChromaDex’s bioactive ingredients stable – will follow a similar development path to pterostilbene, a compound found in blueberries it has synthesized to...

‘No logic’ to FDA view on product-specific NDI notifications, says lawyer

There is “no logic” to the FDA’s insistence that NDI (new dietary ingredient) notifications are applicable only to the specific manufacturer that submits them, according to one leading food law...

Lawyer on NDI guidance: FDA is trying to ‘dismantle’ DSHEA

The argument that the FDA has overstepped its legal remit in its draft guidance on new dietary ingredients (NDIs) is gaining ground, with one food law expert claiming the FDA...

Toxicologist: FDA’s NDI guidance is entirely reasonable

Many dietary ingredients used in supplements today bear little resemblance to ingredients that were assumed to be ‘grandfathered in’ post the 1994 Dietary Supplements Health and Education Act, making a...

ABC on NDI guidance: ‘We find this problematic’

The American Botanical Council (ABC) has weighed into the debate over the Food and Drug Administration’s (FDA’s) draft guidance document on new dietary ingredient (NDI) notifications.